IBM® MarketScan®
Purpose
IBM® MarketScan® is a service provided by the Office of Chief Research Informatics Officer (CRIO).
MarketScan® Research Databases from IBM® provides one of the longest-running and largest collections of proprietary de-identified claims data for privately and publicly insured people in the U.S.
Currently available years analyzed – 2013-2017
1. MarketScan Commercial Claims and Encounters Database (CCAE) – contains data from active employees, early retirees, COBRA continuees, and dependents insured by employer sponsored plans (i.e., individuals not eligible for Medicare).
2. MarketScan Medicare Supplemental and Coordination of Benefits Database (MDCR) – created for Medicare-eligible retirees with employer-sponsored Medicare Supplemental plans. This database contains predominantly fee-for-service plan data.
Office
Office of Chief Research Informatics Officer (CRIO)
Access
The following documents are required for each member of the research team:
- Mount Sinai HIPAA training certificate. Certificates of completion can be found at Mount Sinai PEAK
- CITI Basic Course and Refresher (if due) training certificates. Information for required certificates is here
- Terms of Use for MarketScan®
Please open a request ticket here and select CRIO / MarketScan® Request as the Help Topic
Data stored in MarketScan® Server is accessed, analyzed, and used only on the server.
MarketScan® data is accessible using SAS application launched from Citrix Workspace.
Note:
IBM forbids the use of its data by Mt Sinai students, postdocs, or staff for their own independent research. PhD students can request a dissertation-support data set through IBM. This is the only data set we can allow for student projects. Refer to the IBM MarketScan Dissertation Support Program.
Cost
There is no cost to end users for internally funded studies. For externally funded studies, there is an end-user fee to use the school-acquired data sets in non-commercial projects of $30,000 per study. There is an end-user fee to use the data in commercially funded studies of $60,000 per study. The end-user fees are standard for IBM® licensing agreements with academic medical centers.